Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
LGND
LGND
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LGND News
Ligand Pharmaceuticals Director Sells Shares
5d ago
Fool
Kozarich Sells Shares of Ligand Pharmaceuticals
5d ago
NASDAQ.COM
Ligand Pharmaceuticals to Host Investor Day in New York City
Jun 10 2026
Newsfilter
Ligand Executive Sells $1.14 Million in Stock Following Options Exercise
Jun 07 2026
Fool
Ligand Executive Sells Shares to Supplement Income
Jun 07 2026
NASDAQ.COM
Ligand Executive Sells 5,000 Shares for $1.1 Million
Jun 07 2026
Yahoo Finance
Legend Biotech Reports Promising Early Results for LB2501 CAR-T Therapy
Jun 02 2026
seekingalpha
Ligand Pharmaceuticals Q1 Earnings Announcement Scheduled
May 06 2026
seekingalpha
Investigation Alerts for Multiple Company Mergers
May 05 2026
Globenewswire
Latest Developments in the Biotech Sector
Apr 30 2026
NASDAQ.COM
Investigation into XOMA Royalty Acquisition
Apr 27 2026
PRnewswire
Investigation Alerts for Multiple Mergers
Apr 27 2026
Globenewswire
Ligand Pharmaceuticals to Acquire XOMA Royalty for $739 Million
Apr 27 2026
NASDAQ.COM
Ligand Pharmaceuticals to Acquire XOMA Royalty for $739 Million
Apr 27 2026
seekingalpha
Ligand Pharmaceuticals to Acquire XOMA for $740M in Cash
Apr 27 2026
seekingalpha
XOMA STOCK RISES 5.4% IN PREMARKET TRADING FOLLOWING REPORT OF LIGAND PHARMACEUTICALS ACQUIRING COMPANY FOR ALMOST $740 MILLION
Apr 27 2026
moomoo
Show More News
